Cite
Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease.
MLA
Champion, Christophe, et al. “Comparison between Three Promising SS-Emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease.” Theranostics, vol. 6, no. 10, June 2016, pp. 1611–18. EBSCOhost, https://doi.org/10.7150/thno.15132.
APA
Champion, C., Quinto, M. A., Morgat, C., Zanotti-Fregonara, P., & Hindié, E. (2016). Comparison between Three Promising ß-emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease. Theranostics, 6(10), 1611–1618. https://doi.org/10.7150/thno.15132
Chicago
Champion, Christophe, Michele A Quinto, Clément Morgat, Paolo Zanotti-Fregonara, and Elif Hindié. 2016. “Comparison between Three Promising SS-Emitting Radionuclides, (67)Cu, (47)Sc and (161)Tb, with Emphasis on Doses Delivered to Minimal Residual Disease.” Theranostics 6 (10): 1611–18. doi:10.7150/thno.15132.